Key transcription factors in the differentiation of mesenchymal stem cells

Abstract

Mesenchymal stem cells (MSCs) are multipotent cells that represent a promising source for regenerative medicine. MSCs are capable of osteogenic, chondrogenic, adipogenic and myogenic differentiation. Efficacy of differentiated MSCs to regenerate cells in the injured tissues requires the ability to maintain the differentiation toward the desired cell fate. Since MSCs represent an attractive source for autologous transplantation, cellular and molecular signaling pathways and micro-environmental changes have been studied in order to understand the role of cytokines, chemokines, and transcription factors on the differentiation of MSCs. The differentiation of MSC into a mesenchymal lineage is genetically manipulated and promoted by specific transcription factors associated with a particular cell lineage. Recent studies have explored the integration of transcription factors, including Runx2, Sox9, PPARγ, MyoD, GATA4, and GATA6 in the differentiation of MSCs. Therefore, the overexpression of a single transcription factor in MSCs may promote trans-differentiation into specific cell lineage, which can be used for treatment of some diseases. In this review, we critically discussed and evaluated the role of transcription factors and related signaling pathways that affect the differentiation of MSCs toward adipocytes, chondrocytes, osteocytes, skeletal muscle cells, cardiomyocytes, and smooth muscle cells.

Keywords: Mesenchymal stem cells; Multilineage differentiation; Transcription factors.

Figure 1

Mesenchymal stem cells differentiate into osteoblast, chondrocyte, myoblast, fibroblast and adipocyte, depending on the stimuli in the differentiation-induction media (in vitro).

Figure 2

Major transcription factors that promote differentiation of mesenchymal stem cells into osteocytes, chondrocytes, adipocytes, smooth muscle cells, skeletal muscle cells, and cardiomyocytes.